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Abstract. Transforming growth factor-ßl (TGF-ßl)
has been shown to up-regulate the synthesis of nerve
growth factor (NGF) in cultured rat astrocytes and in
neonatal brain in vivo (Lindholm, D., B. Hengerer,
R Zafra, and H. Thoenen. 1990. NeuroReport.
1:9-12). Here we show that mRNA encoding TGF-01
increased in rat cerebral cortex after a penetrating
brain injury. The level of NGF mRNA is also tran-
siently increased after the brain trauma, whereas that
of brain-derived neurotrophic factor remained un-
changed. In situ hybridization experiments showed a
strong expression of TGF-01 4 d after the lesion in
cells within and in the vicinity of the wound. Staining
of adjacent sections with OX-42 antibodies, specific
T
RANSFORMING growth factor-ßl (TGF-ßl)' belongs
to a family ofstructurally relatedproteins, the TGF-ßs,
which have multiple effects on the growth and differen-
tiation of various cells (Sporn et al ., 1987; Massague et
al., 1987). So far five different TGF-ßs (TGF-ßl-TGF-ß5)
have been identified. Among them, TGF-ß1, TGF-ß2, and
TGF-ß3 are foundin mammaliantissues (Roberts and Sporn,
1990). TGF-01 is especially abundant in platelets (Àssoian
et al., 1983) and bone tissue (Seyedin et al., 1986) and the
molecule is thought to play an important role in the healing
of wounds and in bone formation. The exact mechanism(s)
by which TGF-01 acts is not fully understood, but TGF-ßl
has been shown to enhance the expression of specific genes
(Rossi et al., 1988)and to influence the metabolism ofextra-
cellular matrix components (Rizzino, 1988 ; Roberts and
Sporn, 1990). Although many cells have been shown to pro-
duce the molecule, TGF-01 in tissues is usually present in
a latent, biologically inactive form (Wakefield et al., 1988).
Available data indicate that high molecular weight proteins
which bind to TGF-ß inactivate the molecule (Miyazono et
al ., 1988; Tsuji et al., 1990). Latent, high-molecular weight
TGF-ß can be converted into active TGF-01 by proteolytic
1. Abbreviations usedinthis paper: bFGF, basic FGF; BDNF, brain-derived
neurotrophic factor; GFAP, glial fibrillary acidic protein; LPS, lipopolysac-
charide; NGF, nerve growth factor; IL-1, interleukin-1; TGF-ß, transform-
ing growth factor ß.
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for macrophages and microglia/brain macrophages, re-
vealed a similar pattern of positive cells, suggesting
that invading macrophages, and perhaps reactive
microglia, are the source of TGF-01 in injured brain.
Both astrocytes and microglia express TGF-01 in cul-
ture, and TGF-ßl mRNA levels in astrocytes are in-
creased by various growth factors, including FGF,
EGF, and TGF-# itself. TGFRf 1 is a strong inhibitor
of astrocyte proliferation and suppresses the mitotic
effects of FGF and EGF on astrocytes. The present
results indicate that TGF-01 expressed in the lesioned
brain plays a role in nerve regeneration by stimulating
NGF production and by controlling the extent of astro-
cyte proliferation and scar formation.
enzymes (Lyons et al., 1988)or by removal ofcarbohydrates
from the latent molecule (Miyazono and Heldin, 1989).
TGF-01 is thought to be activated during tissue reaction to
trauma, and the molecule profoundlyinfluences cellular pro-
cesses associated with wound healing (Roberts and Sporn,
1990). In support of this view, TGF-01 has been shown to
enhance the healing of incisional wounds in rats (Mustoe et
al ., 1987) .
TGF-01 is present in low amounts in normal brain (Wilcox
and Derynck, 1988) and the protein has been localized im-
munohistochemically to meningeal cells (Heine et al.,
1987). However, in a recent study (Flanders et al., 1991) it
was demonstrated that TGF-ß2 and TGF-ß3 are present in
brain during early mouse development.
We have previously shown that TGF-01 stimulates the ex-
pression ofNGF in cultured rat astrocytes and that it elevates
nerve growth factor (NGF)-mRNA in neonatal rat brain in
vivo (Lindholm et al., 1990). Here we report that TGF-ßI-
mRNA increases in rat brain after a lesion and that this in-
crease precedes the elevation of NGF-mRNA in the injured
cortex. In situ hybridization localized TGF-ßl mRNA to cells
within and surrounding the brain wound. The TGF-ßl-la-
beled cells were mainly macrophages and perhaps reactive
brain microglial cells (Perry and Gordon, 1988 ; Streit et al.,
1988) as shown by staining of adjacent sections with OX-42
antibodies specific for these cells (Robinson et al ., 1986) .
Both rat microglia cells and astrocytes express TGF-01 in
395culture, but in contrast to astrocytes (Lindholm et al ., 1990)
the levels of TGF-ßl mRNA in microglial cells are not up-
regulated by TGF-ßl . Since TGF-01 has a strong inhibitory
effect on astrocyte proliferation TGF-01 released from mac-
rophages and microglial cells may control glial cell prolifer-
ation and scar formation after brain injury.
MaterialsandMethods
Porcine platelet TGF-01 was obtained from R .& D. Systems Inc . ; EGF and
lipopolysaccharide (LPS) from Sigma Chemical Co. (St . Louis, MO) ; bo-
vine basic FGF (bFGF) from Amersham International (Amersham, UK) ;
glial fibrillary acidic protein (GFAP) antibody from Boehringer Mannheim
(Germany) ; OX-42 antibody from Serotec (UK) ; andABC Elite kits (Vector
Labs) from Carrion (Wiesbaden, Germany) .
AnimalsandSurgical Procedures
Wistar rats weighing 180-200 g were deeply anesthetized with chloralhy-
drate (4% solution) and placed in a sterotaxic device . The treatments of
animals were performed according to the ethical rules approved by the
government of Bavaria. Anantero-posterior surgical cut (5mm long, 2mm
deep) was made in the cortex 2mm lateral from the midline . The skull was
closed with dental cement and the animals were allowed to recover. After
various periods of time, the rats were decapitated under ether anaesthesia
and the brain tissuesurrounding the wound (-70-90 mg) aswell asanequal
part ofthe contralateral, unoperated cortex weredissected out and immedi-
ately frozen in liquid nitrogen .
Cell Cultures
Astrocytes were prepared from brains of newborn Wistar rats as described
earlier (McCarthy and de Vellis, 1980) and were cultured in DME sup-
plemented with 10% (vol/vol) FCS. After -2 wk of incubation the
confluent cultures were shaken to remove microglia and oligodendrocytes
(Sprenger et al ., 1990) and the astrocytes were plated onto 35-mm Falcon
dishes . Cultures were >95% pure as evaluated by staining with GFAP, a
marker for astrocytes . Microglial cells were identified by staining with
nonspecific esterase and by their different morphology (Sprenger et al .,
1990) . Before the experiments with growth factors the cells were kept in
DME in low, 1% (vol/vol) serum for 2 d . To determine the mitogenic activ-
ity of interleukin-1 (IL-1), bFGF, and EGF, the astrocytes were incubated
for 24h in the absence orpresence ofTGF-ßl. Duringthe last 6h ofincuba-
tion 3[H]thymidine (2 uCi/ml) was present and the amounts of TCA-
insoluble radioactivity in the cells were subsequently determined .
RNA Hybridization
RNA was prepared from cultured cells and from brain samples as described
earlier (Lindholm et al ., 1988) . To correct for variation in recovery ofRNA
between samples, a 0.51-kb NGF mRNA transcript, made in vitro, was
added to the samples before the extraction procedure. RNA was glyox-
ylated, electrophoresed through a 1 .5 % agarose gel, and transferred to ny-
lon filters (Hybond N ; Amersham International) . The filters were hybrid-
ized using 50% formamide and 32P-labeled complementary RNA (cRNA)
probes (Heumann et al ., 1987; Lindholm et al ., 1990) . After washing of
the filters they were exposed for various periods of time and the amounts
ofspecific transcripts present were determined by laser scanning of the au-
toradiograms (Lindholm et al ., 1988) .
32P-labeled cRNA probes specific for NGF (Scott et al ., 1983), brain-
derivedneurotrophic factor (BDNF) (Hoferet al ., 1990), TGF-01 (kind gift
of Dr. F. Lee, DNAX Inc ., Stanford, CA), and TGF-ß3 (Lindholm et al .,
1990) were obtainedusing run-ontranscription ofthe corresponding mouse
cDNAs, which were subcloned into the pGemini vector (Lindholm et al .,
1990 ; Zafra et al ., 1990) .
Immunohistochemistry ofBrain Cells
For immunohistochemical analysis, 12-Km-thick cryostat sections were cut
on a freezing microtome and mounted on glass slides . The cryosections
were briefly dried and fixed in 3.7% buffered formalin, followed by 2 min
in each of 50, 100, and 50% acetone at room temperature (Kiefer and
Kreutzberg, 1990) . After several washes with PBS, sections were incubated
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with primary antibody for 1 h at room temperature. The monoclonal anti-
GFARantibody specific for astrocytes was used at a dilution of 1:100, the
mAb, OX-42, directed against rat complement C3bi receptor present on
subsetsofmacrophages and dendritic cells (Robinson et al ., 1986) was used
at a dilution of 1:1,600. Sections were then sequentially incubated with bi-
otinylated secondary antibody, avidin-biotinylated HRP complex anddevel-
oped with a solutioncontaining 3,3 DAB andHRPas peroxidase substrate .
In Situ Hybridization
Frozen lesioned brains were cut into 12-Am-thick sections and mounted on
gelatin-coated glass slides . Sections were fixed for 30 min in 446 buffered
paraformaldehyde at 4°C and rinsed twice in PBS . They were then treated
with acetic anhydride (0.2546 in 0.1 M triethanolamine, pH 8.0) for 15 min,
rinsed in the same buffer, and dehydrated . Hybridization buffer (50% for-
mamide, 0.3M NaCl, 2mM Tris, pH 8, 1 mM EDTA, Ix Denhardt's, 0.5
mglml tRNA, 100mM DTT, and 10% dextran sulphate) was supplemented
with 10,000 cpm/Fel of sense or antisense TGF0 cRNA probe previously
digested to the length of -150 bases . After an overnight hybridization at
50°C, the sections were washedin lx SSC for 60 min at room temperature
followed by a stringent wash (50% formamide, 65°C, 30 min) and RNase
treatment . The stringent wash was repeated, and the slides were rinsed in
0.1x SSC for 5 min and rapidly dehydrated . The sections were exposed to
Hyperfilm (Amersham International) or NTB-2 emulsion (Eastman Kodak
Co., Rochester, NY) for 14 and 20 d, respectively.
Results
TGF-01 mRNA Increases afterBrain Injury
Earlier studies have shown that TGF-ßl mRNA is present at
very low levels in developing mouse brain (Wilcox and
Derynck, 1988) . As shown by RNA hybridization in Fig . 1,
mRNA encoding TGF-01 is expressed in normal rat brain
(cerebral cortex) albeit at a very low level . However, the lev-
els of TGF-ßl-mRNA increased three- to-fourfold after a
penetrating injury (stab wound) to the cerebral cortex . The
increase in TGF-01 mRNA became apparent after one day
(Fig. 1) and was more pronounced at day seven after lesion
(Fig. 2) . On the other hand, mRNA encoding NGF increased
only transiently, 2.5-fold, in cerebral cortex 3 d after the le-
Figure 1. Hybridization ofRNA from brain cortex 1 d after a pene-
trating wound . Total RNA of tissue from lesioned (L) or from the
contralateral brain cortex (C) were isolated and analyzedby North-
em blots (see Materials and Methods) . Each lane represents tissue
from an individual animal . The filters were sequentially hybridized
with specific cRNA probes forNGF and TGF-ßl . TGRßl mRNA
migrated as a 2.5-kb band and NGF mRNA as a 1.3-kb band .
STANDARD is a band corresponding to a NGF recovery standard
added to the samples before RNA extraction (see Materials and
Methods) .
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TGF-ßl and NGF mRNA lev-
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sion and the NGF mRNA levels subsequently returned to
normal (Fig. 2). A summary of the changes in TGF-ß and
NGF mRNAs following the penetrating wound are shown in
Fig. 2. The mRNA levels for BDNF, another member of the
NGF gene family (Leibrock et al., 1989), were not
significantly changed after the brain injury (Fig. 2) .
In Situ HybridizationofTGF-01 in Lesioned Brain
To localize TGF-ßl mRNA in the injured brain we used
specific sense and antisense riboprobes for TGF-ßl. Fig. 3
shows the presence of cells expressing TGF-ßl in tissue
around the brain wound at 4 d after surgery with no cells
positive using the sense strand for hybridization . TGF-ßl
was not detectable by in situ hybridization in the normal
brain. Emulsion autoradiography demonstrated that cells
concentrated at the margin of the wound were strongly la-
beled for TGF-ßl, but some labeled cells were also observed
in the surrounding brain parenchyma (Fig. 3). Staining of
adjacent sections with anti-GFAP (marker for astrocytes)
and OX-42 antibodies (marker for macrophages and
microglial cells) revealed a similar distribution of cells ex-
pressing TGF-ß and positive for OX-42 (Fig. 3) . Cells
stained with GFAP were found further away from the wound
area and the GFAP staining was usually weak (data not
shown) . However, not all cells within the wound were posi-
tive for TGF-ßl as shown by the lack of grains in some cells
in the larger magnification in Fig. 3 d.
Regulation ofTGF-01 mRNA in Glial Cells
To study how TGF-ßl is regulated in glial cells the levels of
TGF-ßl mRNA were determined in cultured astrocytes and
microglial cells. As shown in Fig. 4, rat astrocytes contain
low levels of TGF-ßl mRNA. However, various growth fac-
tors such as EGF, FGF, and TGF-ßl itself up-regulate the
levels of TGF-ßl mRNA in these cells. TGF-ßl and FGF
added together to the astrocyte cultures resulted in a larger
increase in TGF-ßl expression as seen with either factor
alone suggesting that these two factors act synergistically in
stimulating TGF-ßl expression. The effects of EGF and FGF
on TGF-ßl mRNA levels were specific since mRNAencod-
ing TGF-ß3, another member of the TGF-ß gene family
(Derynck et al ., 1988; ten Dijke et al ., 1988), was not in-
duced by these growth factors (Fig. 4). However, TGF-,ßl
and TGF-ß2 increased the levels of TGF-ß3 mRNA in astro-
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cytes, indicating that there is a positive interaction of the
different TGF-ß proteins in these cells.
As shown in Fig. 5 cultured microglial cells express
TGF-ßl, but in contrast to astrocytes the levels of TGF-ßl
mRNA in the microglial cellswere not significantly elevated
by TGF-ßl (Fig. 5). LPS, which is known to activate macro-
phages, did not induce TGF-ßl mRNA in microglial cells
(Fig. 5). On the other hand, LPS elevated the NGF-MRNA
in microglial cells which normally express very low NGF-
mRNA levels (Fig. 5) .
Effect ofTGF-01 on Astrocyte Proliferation
TGF-ßl affects growth of many cells and either inhibits or
stimulates cell division depending on the conditions and the
presence of other growth factors (Moses, 1990). The cells
were incubated in the absence or presence of different con-
centrations ofTGF-ßl to study whether TGF-ßl affects astro-
cyte proliferation. TGF-ß reduced thymidine incorporation
in astrocytes (50°ío inhibition) incubated in 10% FCS and a
concentration of 0.1 ng/ml already had an inhibitory effect
(data not shown) . To test for various growth factors the astro-
cytes were incubated in low, I% FCS in the absence or pres-
ence of TGF-ßl. As shown in Table I, TGF-ßl substantially
counteracted the positive mitotic effect on astrocytes ob-
served with various growth factors, such as IL-1, bFGF,
and EGF.
Discussion
The present study shows that TGF-ßl mRNA significantly
increases in lesioned rat brain cortex after a penetrating in-
jury. The increase in TGF-ßl expression occurred within the
first day after the injury and the mRNA was elevated for at
least 1 wk. The levels of NGF mRNA as detected by RNA
hybridization were also transiently increased 3 d afterlesion,
whereas the BDNF mRNA levels stayed constant.
Considering the magnitude of changes in TGF-ßl and
NGF-mRNAs, data based on RNA analyses of tissue sur-
rounding the wound are likely to underestimate changes in
gene expression due to the presence of normal tissue in the
samples. Thus, for example the lesion-mediated increase in
the expression of heat shock protein in brain cortex was
confined to the tissue adjacent to the wound (Brown et al .,
1989). The in situ hybridization experiments revealed that
the increase in TGF-ßl mRNA was indeed strongest in cells
Table L Effect of Various Growth Factors and TGF-01 on
Astrocyte Proliferation
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Astrocytes were plated onto a 24-well Costar dish in 0.5 nil mediumcontaining
1 .0% FCS. After 1 d of incubation various growth factors were added and the
incubation carried out for another 24 h. During the last 6 h radioactive thymi-
dine (2 pCi/n31) was present. The TCA-insoluble radioactivity was determined
as described in Materials and Methods. The values represent means + SEM
(n = 5-6 experiments).
3[H]-thymidine incorporation (cpm/5 x 10° cells)
Treatment - TGF-ßl + TGF-01
Control 2,205 + 106 853 + 34
IL-1 (3 ng/ml) 3,405 + 78 918 + 47
FGF (5 ng/nil) 8,572 + 264 3,985 + 204
EGF (5 ng/ml) 9,608 + 589 6,349 + 142Figure 3. TGF-ßl in situ hybridization and OX-42 immunostaining ofcells in brain cortex 4 d after lesion . a represents in situ hybridization
using a specific anti-sense TGF-ßl riboprobe (see Materials and Methods) . Cells are highly TGF-ßl mRNA positive within the vicinity of
the wound . Scattered cells are also labeled at some distances away from the wound margin . b represents staining of sections with the macro-
phage- and microglial-specific antibody, OX42 (see Materials and Methods) . Intense staining ofcells is observed withinand around thebrain
wound . The pattern of immunostaining corresponds to that seen with TGF-ßl grains in a . c represents in situ hybridization ofthe sections
usingaTGF-ß 1 sense probe . No cells are specifically labeled . (d)Ahigher magnificationofthe section shows thepresenceofTGF-ß1-specific
grains within some cells (large arrows), whereas some cells were negative (small arrows) . The cells were counterstained with cresyl violet
to reveal the nuclei . Bars : (A-C) 400 ,um ; (D) 20 ,um .
surrounding the wound . Similarly, a local increase in NGF-
mRNA in some cells could also be expected . However, due
to the low levels ofNGFmRNA, we have no direct evidence
to substantiate this view. It has previously been reported that
there is an increase in measurable neurotrophic activity in
brain wounds after three days of injury (Nieto-Sampedro et
al ., 1982), but this activity was not characterized further.
According to this study, part of this neurotrophic activity
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might be NGF (but not BDNF), as NGF mRNA levels were
increased at 3 d after the penetrating brain lesion .
To identify cells expressing TGF-ß after the brain injury,
we performed in situ hybridization combined with immuno-
histochemical staining ofadjacent sections. The similarity in
the pattern of distribution of TGF-01-specific grains and of
OX-42 staining in the brain wound suggest thatthe major cell
type expressing TGF-ß1 after the injury is the macrophage
398Figure 4. Astrocyte expression of TGF-01 and TGF-03-mRNAs :
effect of growth factors . Confluent astrocytes (5 x 105 cells) were
incubated for 12 h in the absence or presence of the growth factors
indicated . Total cellular RNA was isolated and analyzed by hybrid-
ization . The filters were sequentially hybridized with cRNA probes
specific for TGF-01 and TGF-03 to reveal the presence of TGF-01
mRNA (2 .5- and 1.9-kbbands) and TGF-03 (3.5-kb band) . EGF and
FGF were used at 5 ng/ml whereas TGF-01 and TGF-02 were used
at 2 ng/ml . C, controls .
invading the wound cavity . However, sinceOX-42 also stains
resident microglial cells, which are activated after brain in-
jury (Streit et al ., 1988 ; Perry and Gordon, 1988 ; Graeber
et al ., 1988), they might also express TGF-01 in the stab
wound . Thus, scattered cells expressing TGF-01 further
away from the wound edge are probably microglial cells .
The dissimilar distribution ofGFAP staining and TGF-01
positive cells suggest that few astrocytes express TGF-01 af-
ter the brainwound . However, in culture both astrocytes and
microglial cells synthesize TGF-01 as revealed by RNA hy-
Figure 5 . Expression of NGF and TGF-01 mRNAs in microglial
cells : effect of TGF-ßl and LPS. Microglial cells (1.5 x 105 cells)
obtained from primary brain cultures by shaking (see Materials and
Methods) were incubated for 12 h in the presence of TGF-01 (2 ng/
ml) or LPS (10 pg/ml) . Total cellularRNAwas analyzed byNorthern
blots and the filters were hybridized sequentially with probes for
NGF and TGF-01 . STANDARD was as indicated in legend to Fig .
1 . C, controls .
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bridization . There are also some interesting differences in
TGF-01 gene regulation in the glial cells . Whereas TGF-01
itself elevates TGF-01 mRNA levels in cultured astrocytes
(Lindholm et al ., 1990), cultured microglial cells seem to
express TGF-01 mRNA constitutively, thus resembling pe-
ripheral macrophages (Assoian et al ., 1987) . Treatmentwith
lipopolysaccharide did not elevate TGF-,61 mRNA in the
microglial cells butLPS might enhance the release ofTGF-01
protein as shown for peripheral macrophages (Assoian et al .,
1987) . We also found that LPS, as reported earlier (Mallat
et al ., 1989 ; Yoshida and Gage, 1991), induce NGF mRNA
in the microglial cells which normally do not express NGF
(Spranger et al ., 1990) .
After a penetrating injury of the cerebral cortex, macro-
phages and microglial cells are the first cells to become ac-
tive, whereas GFAP-positive astrocytes appear later (Giulian
et al ., 1989) . We found that TGF-01 mRNA increases in the
cortex within 1 d after the injury. Similarly, Nichols et al .
(1991) very recently reported an increase in the levels of
TGF-01 mRNA in hippocampus 2 d after an electrolytic le-
sion of the entorhinal cortex . However, the cellular source
of TGF-01 expression in hippocampus was not character-
ized . Earlier studies have shown an activation of microglia
cells in the deafferented hippocampus (Gall et al ., 1979 ;
Gehrmann et al ., 1992) .
Reactive astrocytes support neuronal regeneration by
secreting various growth factors (Lindsay, 1979 ; Hatten et
al ., 1988 ; Spranger et al ., 1990 ; Lu et al ., 1991) affecting
neuronal survival and differentiation . Various cytokines and
growth factors, such as IL-1 (Giulian and Lachman, 1985)
and FGF (Finkelstein et al ., 1988), increase after brain in-
jury and take part in the cellular processes characteristic of
wound healing . IL-1 (Giulian and Lachman, 1985) as well
as FGF (Perraud et al ., 1988) have been shown to stimulate
astrocyte proliferation which is thought to be part of the as-
trocytic reaction to brain injury (Cavanagh, 1970) . However,
the glial reaction could also inhibit nerve regeneration by
producing a scar which forms a physical barrier to the grow-
ing axons (Bignami and Dahl, 1976 ; Berry et al ., 1983 ;
Reier, 1986) . In this study we found that TGF-01 is a strong
modulator of astrocyte proliferation and at low concentra-
tions inhibits astrocyte mitosis . TGF-01 also counteracts the
positive effects ofbFGF, EGF, and IL-1 on astrocyte prolifer-
ation, suggesting an important role for TGF-01 in the control
of scar formation in the injured brain . In agreement with
the present results, Toru-Delbauffe et al . (1990) recently re-
ported that TGF-01 diminished and delayed DNA synthesis
in astrocytes grown in 10% FCS . We performed our assays
in low (1%) serum to study the effect ofparticular growth fac-
tors, including bFGF and IL-1, known to increase after brain
injury.
TGF-01 has been shown to play an important role in pe-
ripheral wound healing (Mustoe et al ., 1987) by enhancing
cell migration, cell proliferation, and production ofextracel-
lular matrix components (Roberts and Sporn, 1990) . The
present results, showing an increase in TGF-01 mRNA in the
brain wound, suggest that TGF-01 could play an equally im-
portant role in repair mechanisms in the central nervous
system .
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